Viewing Study NCT06176235


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2025-12-25 @ 8:06 PM
Study NCT ID: NCT06176235
Status: WITHDRAWN
Last Update Posted: 2025-08-11
First Post: 2023-12-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia
Sponsor: Peking University People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module